The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.126.10.1404

The authors trace the clinical use of the term "neurasthenia," which began 100 years ago, present theories explaining its etiology, and describe its treatment. The term has remained in use in some European countries including France and Russia, but has become virtually obsolete in the United States. Its recent revival in DSM-II has not yet brought about, to the authors' knowledge, any new interest in this concept.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.